1. Home
  2. GNS vs CALC Comparison

GNS vs CALC Comparison

Compare GNS & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genius Group Limited

GNS

Genius Group Limited

HOLD

Current Price

$0.67

Market Cap

81.8M

Sector

Real Estate

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$6.34

Market Cap

91.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNS
CALC
Founded
2002
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.8M
91.5M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
GNS
CALC
Price
$0.67
$6.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
1.7M
144.6K
Earning Date
09-23-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,749,894.00
N/A
Revenue This Year
$82.78
N/A
Revenue Next Year
$85.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$1.42
52 Week High
$1.92
$6.40

Technical Indicators

Market Signals
Indicator
GNS
CALC
Relative Strength Index (RSI) 49.42 76.69
Support Level $0.62 $4.64
Resistance Level $0.76 $5.34
Average True Range (ATR) 0.06 0.51
MACD 0.00 0.10
Stochastic Oscillator 52.91 90.04

Price Performance

Historical Comparison
GNS
CALC

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: